Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118607754 | 11860775 | 4 | F | 20140922 | 20160720 | 20151222 | 20160726 | EXP | PHHY2014CA127656 | NOVARTIS | 20.37 | YR | F | Y | 0.00000 | 20160726 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118607754 | 11860775 | 1 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 300 MG, EVERY 4 WEEKS | Y | 0 | 300 | MG | |||||||
| 118607754 | 11860775 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | Y | S0060A | 0 | ||||||||
| 118607754 | 11860775 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | Y | S0065E | 0 | ||||||||
| 118607754 | 11860775 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | Y | 0 | |||||||||
| 118607754 | 11860775 | 5 | PS | SEEBRI BREEZHALER | GLYCOPYRROLATE | 1 | Respiratory (inhalation) | QD | U | 207923 | QD | ||||||||
| 118607754 | 11860775 | 6 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 118607754 | 11860775 | 7 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 118607754 | 11860775 | 8 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 2 DF, BID | U | 0 | 2 | DF | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118607754 | 11860775 | 1 | Asthma |
| 118607754 | 11860775 | 5 | Product used for unknown indication |
| 118607754 | 11860775 | 6 | Product used for unknown indication |
| 118607754 | 11860775 | 7 | Product used for unknown indication |
| 118607754 | 11860775 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118607754 | 11860775 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118607754 | 11860775 | Asthma | |
| 118607754 | 11860775 | Cough | |
| 118607754 | 11860775 | Nasal congestion | |
| 118607754 | 11860775 | Nasopharyngitis | |
| 118607754 | 11860775 | Oropharyngeal pain | |
| 118607754 | 11860775 | Sinusitis | |
| 118607754 | 11860775 | Vital capacity decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118607754 | 11860775 | 1 | 20140828 | 0 | ||
| 118607754 | 11860775 | 2 | 20160211 | 0 | ||
| 118607754 | 11860775 | 3 | 20160406 | 0 | ||
| 118607754 | 11860775 | 4 | 20160630 | 0 |